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1. Introduction 
Malaria continues to be one of the major threats to human health, affecting 300-500 million 
people and causing the death of approximately 1 million individuals per year, mostly children 
under 5 years of age (WHO 2010b). Human malaria is caused by five species of the genus 
Plasmodium, namely Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium 
malariae and Plasmodium knowlesi, whereas the latter is found exclusively in the Southeast 
Asian region (Cox-Singh & Singh 2008). Current estimates suggest that approximately 2.4 
billion people are at risk of stable or unstable Plasmodium falciparum transmission, similar 
global estimates are also available for P. vivax, and while there is considerably less mortality 
attributed to this species, its geographical reach is far greater. An estimated 2.9 billion people 
are at risk for vivax malaria, with an estimated 80 million to 300 million clinical cases annually 
(Guerra et al., 2010). These global estimates are a direct result of an increasing ability to collate 
and assimilate large data sets that also allow the monitoring of trends in malaria incidence and 
parasite prevalence. P. falciparum is strongly associated with a potentially fatal form of the 
disease, although recent reports indicate an underestimation of the severity of P. vivax 
infections (Alexandre et al., 2010). Efforts were made to eradicate malaria and although these 
were successful over large geographical areas, they did not succeed in tropical Africa or in 
many parts of Asia. In the past few years, malaria has once again attracted more attention 
partly because of increasing recognition that the malaria prevalence in sub-Saharan Africa has 
increased during the past decade. The main cause of the worsened malaria situation recorded 
in recent years has been the spread of drug-resistant parasites, which has led to rising malaria-
associated mortality, especially in east Africa.  
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The emergence of resistance occurs due to widespread and indiscriminate use of 
antimalarials. This fact exerts a strong selective pressure on malaria parasites to develop 
high levels of resistance. On the other hand, the spread of resistance is due to the existence 
of a sexual cycle in the invertebrate host where there is genetic exchange. 
Antimalarial drug resistance is not the same as malaria treatment failure, which is the 
absence of success in clearing malarial parasitaemia and/or resolve clinical symptoms even 
with the administration of an antimalarial. While drug resistance may lead to treatment 
failure, not all treatment failures are caused by drug resistance. Treatment failure can also be 
the result of incorrect dosing, problems of treatment adherence, poor drug quality, 
interactions with other drugs, compromised drug absorption or misdiagnosis of the patient. 
Apart from leading to inappropriate case management, all these factors may also accelerate 
the spread of true drug resistance by exposure of the parasites to inadequate drug levels 
(WHO 2010b). 
To assess if a strain is resistant to an antimalarial, the World Health Organization (WHO) 
recommended some methods: in vivo assessment of therapeutic efficacy; molecular 
genotyping to distinguish between re-infections and recrudescence; in vitro studies of 
parasite susceptibility to drugs in culture and identification of molecular markers. 
Among the major antimalarial compounds recommended by WHO for treatment of malaria 
are the aminoquinolines (chloroquine, amodiaquine, primaquine, quinine, mefloquine), the 
antifolates (sulfadoxine), diaminopyrimidine (pyrimethamine), sesquiterpene lactones 
(artemisinin, artemether, artesunate) and some antibiotics (WHO 2010a). In counterpart, 
with the exception of artemisinin derivates, there is a widespread drug resistance confirmed 
to all these drugs in many malaria-endemic regions as shown in figure 1 (Ekland & Fidock 
2008). 
 
 
Fig. 1. Emergence of resistance to the principal antimalarials. Each bar represents an 
antimalarial monotherapy or combination. Years to the left of each bar represent the date the 
drug was introduced and the first reported instance of resistance. Chloroquine and 
sulfadoxine/pyrimethamine remained effective for considerable periods after the first 
reported instances of resistance. Artemisinin-based combination therapies (ACTs); 
atovaquone/proguanil (Ato/Pg); sulfadoxine/pyrimethamine (S/P), (Adapted from Ekland 
& Fidock., 2008). 
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Field trials of artemisinin (Qinghaosu) and its derivates were first implemented in China in 
the early 1970s. Artemisinin has a low radical cure rate when used alone in a short course, 
presumably due to its very short half-life in vivo. Since 1994, artemisinin and its derivates 
have been used in combination therapies (ACTs). More recently, in reports about the 
molecular marker SERCA-type PfATPase6 associated to artemisinin-derivate resistance was 
described as possible target of the drug (Eckstein-Ludwig et al., 2003), but some groups do 
not agree about the correlation of mutation of this gene to the artemisinin (Dondorp et al., 
2009; Valderramos et al., 2010). 
Several strategies have been used to control malaria in the world, and these rely on the 
efficient and fast treatment of infected individuals, environmental measures including vector 
control programs and prevention by the stimulation of use of insecticide-treated bednets 
(WHO 2010b). Given the ever-looming surge of resistance of the parasite against the drugs 
currently in use, the development of an efficient vaccine or novel drugs are important issues. 
The symptoms of malaria are linked to the stage of schizogony. After the invasion of 
erythrocyte the parasite consumes and destroys the intracellular proteins, especially 
hemoglobin which is polymerized into an inert substance denominated hemozoin or 
malarial pigment. According to classical symptomatology, fever coincides with lysis of red 
blood cells (RBCs) and is caused by the release into the bloodstream of the hemozoin and 
other toxic parasite products. Coincident with the rupture of erythrocyte occurs the 
increased expression of TNF-ǂ and other cytokines (TNF-ǃ and IL-6) which can also induce 
the release of other mediators (prostaglandin and TGF-ǃ) that are responsible for the onset 
of symptoms (including fever) and tissue damage (Beeson & Brown 2002; Hemmer et al., 
2006). 
P. falciparum is strongly associated with a potentially fatal form of the disease, most affecting 
young children, non-immune adults and pregnant women, although recent reports indicate 
an underestimation of the severity of P. vivax infections (Alexandre et al., 2010). The 
pathogenesis of human P. falciparum infection is a complex interaction of parasite induced 
RBCs alterations (Maier et al., 2009) and microcirculatory anomaly, (Grau et al., 2003) 
accompanied by local and systemic immune reactions, resulting in a accumulation or 
sequestration of parasite infected RBCs in various organs, such as the brain, lung and 
placenta, and together with other factors is important in the pathogenesis of severe forms of 
malaria (Marsh et al., 1995; Buffet et al., 2011). RBC infected with early parasite stages (rings) 
display mild modifications of adhesion and/or deformability properties and may circulate, 
whereas late parasite stages, called trophozoites and schizonts (mature forms), have 
substantial alterations of adhesion and deformability that favor their sequestration in small 
vessels, thus preventing their circulation in the peripheral blood. Sequestration of mature 
forms is induced by their adherence to endothelial cells, blood cells, platelets, and 
uninfected RBCs. These interactions are mediated by multiple host receptors recognized by 
parasite adhesins (Maier et al., 2009). Cerebral malaria is the main clinical manifestation of 
severe P. falciparum infection and seems to be responsible for most deaths. It is characterized 
by coma, often with convulsions (Lalloo et al., 1996). Severe anaemia is probably the second 
most common presentation of severe P. falciparum infection and probably results from RBCs 
destruction, indirect destruction of parasitized erythrocytes by immune mechanisms and 
reduced erythropoiesis associated with imbalances in cytokine concentrations (Menendez et 
al., 2000; Ekvall 2003). Renal dysfunction or failure, circulatory collapse and shock, 
disseminated intravascular coagulation and spontaneous bleeding, and acidosis can also 
occur. Among adults with malaria, pregnant women are particularly susceptible to malaria, 
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despite substantial immunity before pregnancy, and the risk is highest in first pregnancies. 
The major complications of infection are maternal anaemia, which in turn increases 
maternal deaths, and reduced infant birthweight from a combination of intrauterine growth 
retardation and premature delivery leading to excess infant mortality. In some settings 
maternal malaria may also cause spontaneous abortion or stillbirth (Granja et al., 1998). 
Severe clinical forms are uncommon in infections with P. vivax however in countries where 
this parasite is dominating, more and more frequently is becoming common severe cases 
and even deaths to P. vivax infection are reported (Anstey et al., 2009). In Brazil cases such 
as severe rhabdomyolysis (Siqueira et al., 2010) and immune thrombocytopenic purpura 
have been reported (Lacerda et al., 2004) and in south-east Asia, especially in India and 
Vietnam, cases of acute renal failure were documented (Sanghai & Shah 2010). A serious 
problem encountered in the P. vivax infection are hypnozoites, this liver stage that can cause 
relapses many months or even years after the initial infection, and these hypnozoites can 
only be eliminated by additional treatment with primaquine (Watkins & Sibley 2011). 
2. The life cycle of plasmodium  
Laveran was responsible for the discovery of the Plasmodium, observing them in human 
erythrocytes and was the first to describe it in 1880. The life cycle of parasites of humans 
Plasmodium genus is very similar between species, showing two distinct phases. The life 
cycle of malaria parasite is complex, and there are four critical points in the life cycle of 
Plasmodium parasites in which a small number of parasites rapidly multiply to generate 
much larger populations. These life cycle stages are male gamete development, sporozoite 
formation, liver stage development and blood stage asexual reproduction. The first two of 
these processes occur within the mosquito vector, and the second two processes take place 
in the vertebrate host. 
Infective sporozoites from the salivary gland of the Anopheles mosquito are injected into the 
human host along with anticoagulant-containing saliva to ensure an even-flowing blood 
meal. Once entered in the human bloodstream, P. falciparum sporozoites reach the liver and 
penetrate the liver cells where they remain at for 9–16 days and undergo asexual replication 
known as exo-erythrocytic schizogony. Each sporozoite gives rise of thousands of 
merozoites inside the hepatocyte and each merozoite can invade a red blood cell (RBC) 
upon release from the liver. According to the Plasmodium species, the liver phase takes on 
average 6 days (P. falciparum), 10 days (P. vivax), or 15 days (P. ovale and P. malariae). 
Merozoites enter erythrocytes by a complex invasion process, requiring a series of highly 
specific molecular interactions. Asexual division starts inside the erythrocyte and the 
parasites develop through different stages therein. The early trophozoite stage is often 
referred to as the “ring form”. Trophozoite enlargement is accompanied by highly active 
metabolism. The end of this stage is marked by multiple rounds of nuclear division 
withouth cytokinesis resulting in the formation of schizonts. Each mature schizont contains 
up to 32 merozoites and these are released after lysis of the RBC to invade further 
uninfected RBCs. This release coincides with the sharp increases in body temperature 
during the progression of the disease. This cycle takes about 36-48 h in P. falciparum, 48 h in 
P. vivax and P. ovale and 72 h in P. malariae. A small proportion of the merozoites in the 
RBCs eventually differentiate to produce micro and macrogametocytes. These gametocytes 
are essential for transmitting the infection to new hosts through female Anopheles 
mosquitoes. 
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A mosquito taking a blood meal on an infected individual may ingest these gametocytes 
into its midgut, where macrogametocytes form macrogametes and exflagellation of 
microgametocytes produces microgametes. These gametes fuse, undergo fertilization and 
form a zygote. This transforms into an ookinete, which penetrates the wall of a cell in the 
midgut and develops into an oocyst. Inside the oocyst many nuclear divisions occur, 
resulting in thousands of sporozoites and they migrate to the salivary glands for onward 
transmission into another host.  
 
 
Fig. 2. During a blood meal, the mosquito inoculates sporozoites into the human host, 
infecting the liver cells initiating the exo-erythrocytic cycle. The parasites multiply, forming 
the schizonts, which then rupture releasing merozoites. The merozoites infect red blood 
cells, initiating the erythrocytic cycle (differentiating into ring, trophozoite and schizont); 
after the rupture of the red blood cells that contain them, merozoites are released and invade 
other red blood cells; some parasites differentiate into male (microgametocytes) and female 
(macrogametocytes) sexual forms the mosquitoes, by feeding off infected patients, ingest the 
gametocytes; the gametocytes evolve into gametes, and the microgametes penetrate the 
macrogametes generating zygotes, which in turn evolve into motile ookinetes; these invade 
the midgut wall of the mosquito, where they develop into oocysts; where sporogony takes 
place, releasing sporozoites; these migrate to the mosquito salivary gland. 
The erythrocytic stages of the malaria parasite are responsible for the symptoms and 
pathology of the disease (Miller et al., 1994). Immunity against the erythrocytic stages is not 
well understood, although they are important from the vaccine development perspective 
(Good 2001). To a greater or lesser extent, all four species have been cultured or maintained 
www.intechopen.com
 
Radioisotopes – Applications in Bio-Medical Science 
 
32
in vitro; P. falciparum, however, is the only species for which all life cycle stages have been 
established in culture (Hollingdale 1992).  
Cultivation of the intraerythrocytic stages of P. falciparum is vital for many aspects of 
malaria research. The in vitro continuous cultivation of the erythrocytic stages of P. 
falciparum achieved by (Trager & Jensen 1976) was a turning point in the history of malaria 
research. Since the establishment of this technique and refinements thereafter, the pace of 
research on malaria has increased significantly.  
The methods for cultivation of the erythrocytic stages of P. falciparum reported have been 
usefully applied in nearly every aspect of research on malaria: chemotherapy, drug 
resistance, immunology and vaccine development, pathogenesis, gametocytogenesis and 
mosquito transmission, genetics, the basis for resistance of certain mutant red cells, cellular 
and molecular biology and biochemistry of the parasites and of their relationship with their 
host erythrocyte (Trager & Jensen 1997).  
Although several methods have been developed, the technique used for the in vitro culture 
of the intraerythrocytic stages of P. falciparum remains essentially the same as that originally 
described by Trager and Jensen. The protocol described by these authors was based on the 
use of HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)-buffered RPMI tissue 
culture medium supplemented with human serum, erythrocytes and sodium bicarbonate. 
Since then, efforts and time have been invested in trying to improve the in vitro growth of 
the asexual stages of the Plasmodium life cycle. 
The availability of the technique has also spawned efforts to cultivate other malaria 
pathogens, both human and non-human. In most instances, it is more convenient working 
with malarial parasites from non-human hosts because they can be maintained in vivo, 
thereby allowing testing for infectivity of in vitro-cultured stages in the vertebrate host and 
providing an animal model for the study of the parasite in the human host, is as the case 
culture malarial parasites infecting simian, avian, and rode hosts.  
Techniques for cultivation of the exoerythrocytic stages of avian malarial parasites P. 
gallinaceum, P. lophurae, and P. fallax were described by Huff (Huff 1964). Primary cultures of 
hepatocytes from rhesus monkeys (Macaca mulatta) were used to support growth of several 
simian malarias (P. cynomolgi, P. knowlesi, P. coatneyi, and P. inui) (Millet et al., 1988). In a 
later study, the same group used rhesus hepatocytes for cultivation of developmental stages 
of P. fieldi and P. simiovale, two parasites that infect macaques (Millet et al., 1994). 
Erythrocytic development of a number of simian malarial parasites has been studied, 
including that of P. knowlesi, P. cynomolgi, P. fragile, P. gonderi, P. coatneyi, P. inui, P. fieldi, and 
P. simiovale. Some of these aforementioned malarias are non human facsimiles of human 
malarias. Among the rodent malarias, the erythrocytic stages of P. berghei and P. chabaudi 
have been cultivated in vitro (Mons et al., 1983; O'Donovan & Dalton 1993). The rodent 
malarial parasite P. berghei from in vivo-infected livers was maintained in primary cultures 
of rodent liver cells by Foley et al. (Foley et al., 1978). Among the avian malarias, the 
erythrocytic stage of P. lophurae has been cultivated in vitro (Langreth & Trager 1973).  
3. Characterization of Isoprenoid pathway by metabolic labeling 
Widespread resistance to most anti-malarial drugs and the unavailability of an effective 
vaccine have fueled the emergence of malaria in recent years as a major global health and 
economic burden. Despite these hurdles, the field of malaria research has witnessed some 
extremely notable developments in the recent past including sequencing of the malaria 
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genome (Gardner et al., 2002) the application of proteomics to studying malaria life cycle 
(Florens et al., 2002), the malaria transcriptome (Bozdech et al., 2003), and several web 
resources such as Mal-Vac (database of malaria vaccine candidates), PlasmoDB (genome 
database of the Plasmodium genus), and VarDB (database for antigenic variation genes 
families) (Chaudhuri et al., 2008; Hayes et al., 2008; Aurrecoechea et al., 2009). 
A thorough knowledge of the biochemistry of P. falciparum is required in order to develop 
new drugs. This aim can be achieved by two means: either by focusing on validated targets 
in order to generate new drug candidates; or by identifying new potential targets for 
malaria chemotherapy. This last strategy will be commented and discussed in this chapter, 
focusing on the biosynthesis of isoprenoids. In the apicomplexan parasites of the genus 
Plasmodium the isoprenoid pathway is localized in the apicoplast which was acquired 
millions of years ago during an evolutionary event (Lim & McFadden 2010). At this 
occasion, the ancestor of the phylum apicomplexa gained a plastid by the secondary 
endosymbiosis of a photosynthetic eukaryote (McFadden et al., 1996). The chloroplast of this 
photosynthetic eukaryote was retained and during evolution, many chloroplastid genes 
were transferred to the apicomplexan nucleus while others were lost (Funes et al., 2002; 
Moore et al., 2008). In the case of malaria parasites, especially its most virulent species P. 
falciparum, a series of new “plant-like” enzymes associated with this organelle were recently 
discovered (Luo et al., 1999).  
When testing for metabolic activities, usually the cultivable blood stage forms of P. 
falciparum are employed (Trager & Jensen 1976), that we will describe briefly below. Since 
the parasite is an obligate intracellular organism in this stage, several precautions must be 
taken to not confound host cell and parasite metabolic activities. Also, the chemical nature 
of an unlabeled or radiolabeled precursor plays an important role, since some substrates do 
not enter the red blood cell or do not cross the parasitophorous vacuole or the parasite cell 
membrane. Other substrates may require solvents which are toxic to either the parasite or 
the red blood cell. In the following, we describe the progress that was made in the detection 
of a number of metabolic activities of the parasites, many of which configure prime targets 
for drug intervention.  
One of the strategies to identify each product of a metabolic pathway is the metabolic 
labeling using a radioactive specific precursor and a posterior analysis by an appropriate 
method. Due to the difficulty to obtain higher quantities of parasite biomass, the labeling 
with non-radioactive isotopes often does not lead to clear results, for this reason, most 
research groups rely on radiolabeled compounds when monitoring metabolic turnover. 
Several criteria must be evaluated before proceeding to experimental metabolic labeling of 
intraerythrocytic stages of P. falciparum: 1- determine type of study (structural or 
biosynthetic), 2- choose labeling protocol and select a radiolabeled precursor(s), 3– check 
incorporation of radioactivity into the parasite, 4- if the incorporation is sufficient for 
analysis, proceed with steady-state, pulse, pulse-chase or sequential transfer protocols for 
analysis of intermediates of the metabolic pathway to be studied. If incorporation is 
insufficient for analysis, it is recommended to try using more labeled precursor or decrease 
the level of unlabeled precursor in the culture medium. In the next step, it is advantageous 
to check effects on the parasite and molecule(s) of interest and effects on incorporation of 
labeled precursors. Afterwards, the optimal concentration of unlabeled precursor is selected 
and the experiment may proceed with steady-state, pulse, pulse-chase or sequential transfer 
protocols for the analysis of intermediates of the metabolic pathway that is studied. 
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For the characterization the composts isoprenics in parasite, P. falciparum clone 3D7 was 
cultured according to the protocol described by Trager and Jensen (Trager & Jensen 1976) 
where human sera was substituted by Albumax I (0.5%). Parasites were grown in tissue 
culture flasks (75 cm2) a 40 ml volume with a gas mixture of 5% CO2, 5% O2, and 90% N2. In 
asynchronous cultures we can to obtain the ring, trophozoite or schizont stages. In 
synchronous cultures (~ 15% parasitemia), the stage initially was in ring stage (1-20 h after 
reinvasion) after two treatments with 5% (w/v) D-sorbitol solution in water, for subsequent 
maintenance in culture until the differentiation to trophozoite (20-30 h after reinvasion) or 
schizont (30-35 h after reinvasion) stages. Parasite development and multiplication were 
monitored by microscopic evaluation of Giemsa-stained thin smears. 
Cultures of P. falciparum with a parasitemia of approximately 10% were labeled with the 
different precursors in normal RPMI 1640 medium for 15 h and after each stage purified. 
The asynchronous parasites were purified on a 40%/70%/80% discontinuous Percoll® 
gradient (Braun-Breton et al., 1986). The culture was centrifuged at 2000 rpm for 5 min at 
room temperature, the pellet resuspended in RPMI-1640 (1:1 vol/vol), and carefully placed 
on top of the gradient. The tubes were centrifuged at 10,000 x g for 20 min at 20°C. The cells 
containing schizonts, trophozoite and ring stages, respectively were collected, washed twice 
in RPMI-1640, the pellet of parasites were stored in liquid N2 for subsequent analysis. The 
other hand, synchronous culture with schizont stages predominantly were purified with 
magnetic column separation (MACS Separation Columns “CS”). The pre-equilibration, 
washing, and elution the column were all carried out at room temperature with RPMI-1640. 
The culture was centrifuged, the pellet resuspends in RMPI-1640 (1:10 vol/vol), 10 ml of the 
10% suspension of erythrocytes were applied to a CS column assembled in a magnetic unit 
to remove non-infected erythrocytes, ring-infected erythrocytes, and young trophozoites. 
After wash the column by filling from top with 50 ml of RMPI-1640, the column was 
removed from the magnetic field and its contents eluted with 50 ml of RMPI-1640, thus, the 
schizonts stages fraction were obtained, centrifuged at 2,000 rpm for 5 min at room 
temperature, the supernatant discarded, and the pellet of parasites were stored in liquid N2 
for subsequent analysis. Parasite form was monitored by microscopic evaluation of Giemsa-
stained thin smears. 
In the following, we specifically focus i) on the methylerythritol phosphate (MEP) pathway 
which leads to the isoprenoids isopentenyl pyrophosphate (IPP) /dimethylallyl 
pyrophosphate (DMAPP) and ii) on downstream reactions which result in dolichol, 
ubiquinone, menaquinone, tocopherol, carotenoids and other related compounds. 
4. Mevalonate-independent methylerythritol phosphate (MEP) pathway in  
P. falciparum 
The MEP pathway starts with the condensation of pyruvate and glyceraldehyde-3-phosphate, 
which yields 1-deoxy-D-xylulose-5-phosphate (DOXP) as a key metabolite (Rohmer et al., 
1993). Cassera and colleagues showed by metabolic labeling that the MEP pathway is 
functionally active in the intraerythrocytic stages of P. falciparum. Using different radioactive 
precursors such as [1-14C]sodium acetate, D-[U-14C]glucose and [2-14C]deoxy-D-xylulose, five 
intermediates of the MEP pathway were identified. The intermediates were isolated by high 
performance liquid chromatography (HPLC) and characterized by electrospray mass 
spectrometric analyses. All but one of the intermediates of the MEP pathway were 
characterized, including 1-deoxy-D-xylulose-5- phosphate, 2-C-methyl-D-erythritol-4-
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phosphate, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol, 4-(cytidine-5-diphospho)-2-C-
methyl-D-erythritol-2-phosphate, and 2-C-methyl-D-erythritol-2,4-cyclodiphosphate. The 
effect of fosmidomycin on the levels of MEP pathway intermediates was found to be most 
prominent in ring stages followed by schizont stages of P. falciparum. It was also shown that 
the MEP pathway provides IPP precursors for the synthesis of higher isoprenic compounds 
like ubiquinone and dolichol, and this was demonstrated by the decrease in the ubiquinone 
and dolichol content in fosmidomycin-treated parasites (Cassera et al., 2004). To achieve 
efficient labeling, [1-14C] sodium acetate and D-[U-14C] glucose were employed instead of 
pyruvic acid, which is not incorporated by blood stage P. falciparum. These relatively simple 
compounds which enter in many biochemical pathways obviously require a refined analysis of 
synthesized molecules and this was achieved by demonstrating the chemical nature of the 
found molecules by different analytic methods. 
5. Detection of N-linked glycoproteins in P. falciparum  
Glycoconjugates have been shown to be important in the penetration, cellular growth, host 
immunity regulation and differentiation (Schwarz & Datema 1982). The presence of 
glycoproteins in P. falciparum has been demonstrated in several studies but remains 
controversial because there is little information addressing the function of P. falciparum 
glycoconjugated molecules. Also, the few available studies are inconsistent due to differing 
methodologies. N-linked glycosylation is a protein modification that occurs co-translationally 
in the endoplasmic reticulum. Kimura and colleagues described briefly the methodology used 
for detection of N-linked glycoproteins. For this purpose parasite culture containing ring stage 
parasites were labeled for 48 hs with D-[U-14C]glucose or D-[U-14C]mannose. The metabolic 
labeling was also done in the presence of 12 μM tunicamycin, the classic inhibitor of N-
glycosylation. The total profile of glycoproteins was analyzed by SDS-PAGE of treated and 
untreated parasites. The N-linked glycoproteins were confirmed by 18 h radiolabeling with L-
[35S]methionine and affinity chromatography using Concanavalin A-Sepharose. In parallel, 
tunicamycin pre-treated parasites showed a differing band pattern, thus identifying protein 
species which carried N-glycosyl moieties. In order to increase L-[35S]methionine or D-[U-14C] 
glucose labeling, the cultures were starved in methionine- or glucose-deficient medium for 1 h 
before the addition of the radioactive substance (Kimura et al., 1996). By this approach, these 
authors identified N-linked glycoprotein when they used the radioactive precursor D-[U-
14C]glucose. As above, although this form of labeling is unspecific, other methodologies 
confirmed the nature the compounds where radioactive glucose became incorporated. On the 
other hand, Dieckmann-Schuppert et al. (1992) did not detect N-linked glycoproteins using the 
specific 2-[3H]mannose, 6-[3H]glucosamine, or l-[14C]mannosamine. In 1997 Gowda and 
colleagues confirmed that P. falciparum contains low levels of N-glycosylation activity. The 
amount of N-linked carbohydrates in whole parasite proteins is approximately 6% compared 
with the GPI anchors attached to proteins based on radioactive GlcN incorporated into the 
proteins (Gowda et al., 1997). Bushkin et al. (2010) suggested that the occupation of N-glycan 
sites is markedly reduced in apicoplast proteins versus some secreted proteins in Plasmodium. 
Clearly, more work has to be done in order to elucidate the nature and purpose of N-linked 
glycoproteins in Plasmodium. Also, the differences in the results published by distinct groups 
mentioned above may have occurred due to differences in basic aspects of each experiment, 
such as the duration of labeling, the tracing compound used and the parasite stage that was 
analyzed. 
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6. Characterization of dolichol in P. falciparum 
The protein modification by N-linked glycosylation is dependent on the de novo synthesis of 
dolichyl-P, a long chain non-sterol isoprene which acts as a membrane-bound carrier of 
oligosaccharides in the assembly of glycoproteins (Leloir 1977). Couto et al (1999) 
demonstrated the presence of dolichol, dolichyl-P and dolichyl-PP species of 11 and 12 
isoprenic units in parasites of P. falciparum cultivated in vitro. 
In these experiments, cultures of P. falciparum were labeled for 15 h with [1-(n)-
3H]geranylgeranyl pyrophosphate triammonium salt ([1-(n)-3H]GGPP) or with [1-(n)-
3H]farnesyl pyrophosphate triammonium salt ([1-(n)-3H]FPP). Each stage was purified by 
Percoll gradient; the pellets were extracted and analyzed by C18 reverse-phase HPLC (RP-
HPLC). From extracts labeled with [1-(n)-3H]GGPP, 3 major peaks were detected: at 8 min, 
coincident with an authentic sample of geraniol, at 21 min, coincident with a dolichol 
standard with 11 isoprenic units and at 23 min, coincident with a dodecaprenol standard. 
Parasites labeled with [1-(n)-3H]FPP showed a number of other labeled products, but the 
presence of dolichol of 11 and 12 isoprenic units was evident (Couto et al., 1999). 
7. Characterization of ubiquinone and carotenoids in P. falciparum 
Coenzyme Q is a molecule composed of a benzoquinone ring with a side chain of several 
isoprenic units, and the number of which defines the type of coenzyme Q. A polyprenyl 
diphosphate synthase is involved in the elongation of the side chain (Ogura et al., 1997). This 
isoprenic chain is then attached to p-hydroxybenzoic acid (PHBA), which is synthesized via 
the shikimate pathway. The isoprenic chain then allows the molecule to attach to the inner 
membrane of mitochondria, where it participates in many metabolic processes, like the 
electron transport chain (Ernster & Dallner 1995). 
Macedo et al. (2002) had identified coenzyme Q8 and coenzyme Q9 by metabolic labeling of 
parasites with [1-14C]acetic acid, [1-14C]isopentenyl pyrophosphate triammonium salt ([1-
14C]IPP), [1-(n)-3H]FPP, and [1-(n)-3H]GGPP in all intraerythrocytic stages. To our 
knowledge, this was the first report on the incorporation of [1-14C]IPP into P. falciparum. It is 
well known that the considerable increase in total lipid content associated with P. falciparum 
invasion is due to the existence of an intense lipid transport system in infected erythrocytes. 
The efficient uptake of [1-(n)-3H]FPP, [1-(n)-3H]GGPP and, to a lesser extent, [1-14C]IPP, may 
be ascribed to this transport mechanism for lipid-like components. The parasite is capable of 
synthesizing two different homologues of coenzyme Q, depending on the given radioactive 
intermediate. When labeling is performed with [1-(n)-3H]FPP, coenzyme Q with an 
isoprenic chain of 40 carbons (Q8) is detected; while [1-(n)-3H]GGPP labeling leads to Q9 (45 
carbons) chains. These findings can be explained by the fact that both FPP and GGPP are 
substrates of the prenyltransferase involved in the biosynthetic pathway of the isoprenic 
chain of ubiquinone as shown in other systems (Ogura & Koyama 1998). This difference in 
the length of the isoprenic chain according to the precursor was also observed in the 
biosynthesis of dolichols in P. falciparum. In order to check whether this difference could be 
induced by the length of the isoprenoid intermediate, the basic isoprenic unit [1-14C]IPP was 
used as a metabolic marker. It would be expected that by labeling with [1-14C]IPP, both 
coenzymes Q would be detected. Surprisingly, HPLC analysis showed a single radioactive 
peak, which co-eluted with a coenzyme Q9 standard. The enzyme of P. falciparum 
(www.PlasmoDB.org, entry PfB0130w) that biosynthesizes the isoprenic chain attached to 
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benzoquinone ring of coenzyme Q was cloned and expressed and showed octaprenyl 
pyrophosphate synthase activity. Enzymatic activity was measured by determination of the 
amount of [1-14C]IPP incorporated into butanol-extractable polyprenyl diphosphates. The 
recombinant and native versions of the enzyme had similar Michaelis constants with the 
substrates [1-14C]IPP and farnesyl pyrophosphate. The initial rate was calculated by 
determining the quantities of product formed or IPP consumed at each time point by 
counting the 14C radioactivity in the butanol phase (product) and in the aqueous phase 
(IPP). The recombinant protein, as well as P. falciparum extracts, showed an octaprenyl 
pyrophosphate synthase activity, with the formation of a polyisoprenoid with eight 
isoprenic units, as detected by reverse-phase HPLC and reverse-phase TLC, and confirmed 
by electrospray ionization and tandem MS analysis. Additionally, the recombinant enzyme 
could be competitively inhibited in the presence of the terpene nerolidol. Since the P. 
falciparum enzyme shows quite low similarity to its human counterpart, decaprenyl 
pyrophosphate synthase, it was suggested that the identified enzyme and its recombinant 
version could be exploited in the screening of novel drugs (Tonhosolo et al., 2005). The 
enzyme octaprenyl pyrophosphate synthase (PfB0130w) turned out to be a bi-functional 
enzyme with phytoene synthase activity, which was shown by in vitro enzymatic assays 
using [1-(n)-3H]GGPP as a substrate, followed by HPLC analysis and confirmation by LC-
APCI-MS/MS analysis. The identification of the enzyme phytoene synthase showed that 
intraerythrocytic stages of P. falciparum can perform the crucial step of the pathway that 
leads to the biosynthesis of carotenoids. Carotenoids are widespread lipophilic pigments 
synthesized by all photosynthetic organisms and some nonphotosynthetic fungi and 
bacteria. All carotenoids are derived from the C40 isoprenoid precursor geranylgeranyl 
pyrophosphate. HPLC analysis from extracts of intraerythrocytic stages of P. falciparum 
labeled with [1-(n)-3H]GGPP, revealed several compounds in all intraerythrocytic stages, 
with retention times coincident with lutein, phytoene, phytofluene, all-trans--carotene, 
neurosporene and 6-all-trans-lycopene. Some of these compounds were structurally 
characterized by electrospray mass spectrometric analysis (Tonhosolo et al., 2009). 
Considering that carotenoid biosynthesis is absent in humans, and also that possibly other 
uncharacterized carotenoid synthesizing enzymes are present, in Plasmodium, it possible to 
speculate that this pathway could be exploited for the design of new antimalarial drugs. 
Indeed, sequence data from additional organisms, functional studies, improved 
bioinformatics screening approaches, together with biochemical evidence, may reveal 
whether other interesting targets and pathways are present in the phylum Apicomplexa. 
8. Vitamin E biosynthesis 
The biosynthesis of vitamin E depends on both the MEP and shikimate pathways. This 
compound consists of a polar chromanol head group attached to a hydrophobic phytyl 
(tocopherols) or geranylgeranyl (tocotrienols) tail, both of which are critical for their roles as 
lipid-soluble antioxidants (Schneider 2005). 
Using [1-(n)-3H]GGPP or [1-(n)-3H]FPP as radiotracer precursors and HPLC systems for 
purification of vitamin E, the biosynthesis of ǂ and Ǆ-tocopherol was detected in the three 
intraerythrocytic stages from 5x108 parasites. To confirm the chemical identity of these 
compounds, unlabeled extracts from 1010 parasites were purified by HPLC, the retention 
time of tocopherol isomers was collected and analyzed by gas chromatography coupled to a 
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mass spectrometer (GC-MS). Although the two isomers were found in parasites as well as in 
erythrocytes and culture medium extracts, the parasite extracts showed higher 
concentrations than the other samples (Sussmann 2010). 
Usnic acid is a secondary metabolite from lichens and capable to inhibit the 4-
hydroxyphenylpyruvate dioxygenase, an enzyme from the shikimate pathway which is 
responsible for the biosynthesis of homogentisate from hydroxyphenylpyruvate. 
Homogentisate is the aromatic portion which receives the isoprenoid side chain from 
MEP pathway to form vitamin E isomers. When labeled parasites are treated with 25 μM 
of usnic acid, the biosynthesis of ǂ and Ǆ-tocopherol was inhibited in 53,5 ± 7% (Sussmann 
2010). 
9. Menaquinone biosynthesis 
In plants and cyanobacteria the shikimate pathway and MEP provide the precursors for the 
biosynthesis of phylloquinone (PhQ) while in bacteria menaquinone is synthesized 
(Lombardo et al., 2006). Tonhosolo et. al. (2010) showed by metabolic labeling with the 
precursor [1-(n)-3H]GGPP that intraerythrocytic stages of P. falciparum biosynthesizes 
menaquinone (MQ-4), employing different chromatographic methods reported for this type 
of molecule and further confirmed the nature of the molecules by ESI-MS/MS analysis. 
Additionally, they showed that the mycobacterial inhibitor of menaquinone synthesis Ro 48-
8071 also suppressed MQ biosynthesis and growth of parasites, pointing possibly again to 
an interesting drug target. 
10. Posttranslational modification  
10.1 Protein farnesylation and geranylgeranylation in P. falciparum 
Post-translational modification of proteins with isoprenoids was first recognized as a 
general phenomenon in 1984 (Schmidt et al., 1984). The isoprenyl group is linked pos-
translationally to cysteine residues at the C-terminus of the protein through a thioether 
bound (McTaggart 2006). Studies have shown that FPP (15 carbons) and GGPP (20 carbons) 
are the most common isoprenoids found attached to proteins. Several of the proteins that 
undergo these modifications have been identified and may participate in important cell 
regulatory functions, particularly signal transduction pathways (Zhang & Casey 1996). 
Protein prenylation is a general phenomenon in eukaryotic cells and has also been described 
for several protozoan parasites (Lujan et al., 1995; Field et al., 1996; Shen et al., 1996; Ibrahim 
et al., 2001) including P. falciparum (Chakrabarti et al., 2002). 
In order to investigate the presence of isoprenylated proteins in P. falciparum, the labeled 
intermediates [1-(n)-3H]FPP and [1-(n)-3H]GGPP were used. Parasites were incubated with 
radioactive for 18 h, purified on a Percoll gradient, lysed, and analyzed by SDS/PAGE and 
autoradiography. [1-(n)-3H]GGPP labeled proteins appeared in the ring, trophozoite, and 
schizont stages. Non-infected red blood cells showed no incorporation of radioactivity 
under these conditions. The isoprenylated proteins were later identified as members of the 
Ras and Rab protein family (Rodrigues Goulart et al., 2004). 
Moura et al. (2001) and Rodrigues Goulart et al. (2004) showed that terpenes can inhibit 
protein isoprenylation in P. falciparum. The process of protein prenylation is a very 
attractive target for the development of new drugs for cancer and parasites (Docampo & 
Moreno 2001; Stresing et al., 2007). One of the most potent bisphosphonates clinically used 
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to treat bone resorption diseases, risedronate, inhibited the protein isoprenylation in P. 
falciparum (Jordao et al., 2011). In order to investigate the mechanism of action for 
risedronate in intraerythrocytic stages of P. falciparum, parasites were incubated with or 
without risedronate and with [1-(n)-3H]FPP, [1-(n)-3H]GGPP and [14C] IPP, purified on a 
Percoll gradient, lysed, and analyzed by TLC and SDS-PAGE. The results showed that 
protein prenylation is inhibited by decreasing the biosynthesis of farnesyl pyrophosphate 
and geranylgeranyl pyrophosphate. Additionally, it was demonstrated that risedronate 
inhibits the transference of [1-(n)-3H]FPP to proteins but not the [1-(n)-3H]GGPP in P. 
falciparum. 
10.2 Protein dolichylation in P. falciparum 
Another type of protein modification is the attachment of a dolichyl group to proteins. This 
type of modification is characterized by covalently and post-translationally bound dolichyl 
groups to the C-terminal cysteine residues of proteins. Protein dolichylation was described 
in tumor cells and dolichylated proteins could be involved in the cell cycle control 
(Hjertman et al., 1997). 
Our group has previously shown that P. falciparum synthesizes dolichols of 11 and 12 
isoprene units (Couto et al., 1999) and that these compounds can be attached to a group of 
21–24 kDa proteins of this parasite (Moura et al., 2001). To confirm the existence of dolichyl 
groups attached to P. falciparum proteins, D’Alexandri et al. (2006) performed in vitro 
metabolic labeling of the parasites with [1-(n)-3H]FPP or [1-(n)-3H]GGPP. They used these 
precursors instead of [3H]dolichol for analysis of protein dolichylation because 
commercially available [3H]dolichol has dolichols of 16 and 21 isoprene units that are longer 
than those synthesized by P. falciparum. After metabolic labeling, the proteins were 
extracted, extensively delipidated and analyzed by SDS–PAGE. RP-TLC and RP-HPLC 
analysis of [1-(n)-3H]FPP-labeled compounds released from the 21 to 28 kDa from P. 
falciparum proteins revealed that a dolichol of 11 isoprene units and a polyisoprenoid of 12 
isoprene units can be attached to proteins of this parasite. The dolichol structure was 
confirmed by electrospray-ionization mass spectrometry analysis. Treatment with protein 
synthesis inhibitors and RP-HPLC analysis of the proteolytic digestion products from 
parasite proteins labeled with [35S]cysteine and [1-(n)-3H]FPP showed that the attachment of 
dolichol to protein is a post-translational event and probably occurs via a covalent bond to 
cysteine residues. This was the first demonstration of protein dolichylation in parasites, and 
also may represent a new potential target for anti-malarial drugs. 
11. Concluding remarks 
The use of radioactive tracers in metabolic labeling in cultures of P. falciparum allowed the 
identification of many steps of the isoprenoid biosynthesis. In figure 3 we summarize the 
intermediaries’ biosynthesizing by the MEP pathway and the isoprenoids identified in P. 
falciparum until the moment. This pathway is different from the human host and we 
hypothesize that the identification of related enzymes may directly lead to the development 
of new antimalarial drugs. In many aspects, radiotracers are important, often indispensable 
tools for the identification of metabolic intermediates not only in Plasmodium but also in 
many other intracellular protozoa and may ultimately help to point to yet undetected novel 
drug targets.  
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Fig. 3. Isoprenoids biosynthesized by P. falciparum. IPP and DMAPP are biosynthesized by 
the 2-C-methyl-D-erythritol (MEP)-4-phosphate pathway. Shaded boxes indicate presence 
the isoprenoids biosynthesized by malaria parasite identified until this moment. White 
boxes indicate radioactive tracers used for identification of products biosynthesized by P. 
falciparum. PfBO130w correspond to a bi-functional enzyme octaprenyl pyrophosphate 
synthase/phytoene synthase that use [1-14C]IPP or [1-(n)-3H]GGPP respectively as 
substrate. 
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